Publication at First Faculty of Medicine |
2011
Abstract
Breast cancer is the leading malignancy in women. A relatively wide range of therapeutic options are available for breast cancer treatment, depending on the biological nature of the tumor.
Nevertheless, some patients with chronic advanced breast cancer with bone and parenchymal metastasis may run out of therapeutic options. Therefore, any of the effective therapeutic modalities is always worth cansidering.
Recently, anthracyclines have been unjustly forgotten.